Skip to content
Project Directory
  • Français
Donate Now
  • Français
  • About
    • What We Do
    • EDI Action Plan
    • Leadership
    • Team
    • Annual Report
    • Publications
    • Careers
  • Brain Conditions
    • One Brain
    • ALS
    • Autism (ASD)
    • Brain Cancer
    • Brain Injury
    • Dementia
    • Epilepsy
    • Mental Illness
    • Multiple Sclerosis
    • Parkinson’s
    • Stroke
    • More
  • Research
    • Programs
    • Funding Opportunities
    • Program Partners
    • Announcements
  • Impact
    • Research Impact Stories
    • Equity, Diversity and Inclusion
    • Our Donors
    • Brain Health in Indigenous Communities
    • Women’s Brain Health
    • Mind Over Matter
  • How You Can Help
    • Ways to Give
    • Start a Fundraiser
    • Workplace Giving
    • The Great Minds

Funded Grants

Back to results

Decoding Regional Neuroinflammation in Alzheimer’s Disease Through Seeding–Proteome–Spatial Integration

Project Overview

Alzheimer’s disease (AD) affects nearly one million Canadians and remains without a cure. Although most research has focused on the build-up of abnormal proteins such as amyloid and tau, we now know that inflammation in the brain’s immune system plays a major role in how the disease starts and progresses. What remains unknown is where in the brain these immune reactions begin and how they relate to the toxic proteins that spread through the brain. This project aims to map inflammation across different brain regions from people who donated their
brains for research after living with Alzheimer’s disease. We will study both young-onset AD (symptoms before age 65) and late-onset AD, since younger patients often have a faster disease course that may be driven by different immune responses. Using advanced laboratory methods, our team will measure thousands of inflammatory proteins and detect very small amounts of abnormal tau, amyloid, and other proteins such as α-synuclein and TDP-43—both also linked to Parkinson’s and other brain disorders. By combining these results, we will create the first regional “map” of inflammation in Alzheimer’s brains.

Next, we will use cutting-edge imaging mass cytometry, a technology that allows dozens of cell types and immune signals to be visualized in a single tissue section. This will show precisely which immune cells—such as microglia and astrocytes—are active around abnormal proteins and how they interact. Together, these studies will reveal how inflammation and toxic proteins influence one another, and why these processes differ between younger and older patients. The results will help guide future treatments that target the brain’s immune system and improve the development of early-detection tests in blood or spinal fluid.

Principal Investigator

Carmela Tartaglia , University Health Network

Team Members

Gabor Kovacs, University Health Network

Jennifer Gommerman, University of Toronto

Ivan Martinez-Valbuena, University Health Network

Joan Wither, University Health Network

Mohit Kapoor, University Health Network

Valeria Ramaglia, University Health Network

Partners and Donors

Krembil Foundation

Project Ongoing

Decoding Regional Neuroinflammation in Alzheimer’s Disease Through Seeding–Proteome–Spatial Integration

  • Grant Type

    Team grants

  • Area of research

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Competition

    Accelerator Grants: Neurodegeneration x Immunology

  • Province

    Ontario

  • Start Date

    2026

  • Total Grant Amount

    $300,000

  • Health Canada Contribution

    $150,000

Contact Us

1200 McGill College Avenue
Suite 1600, Montreal, Quebec
H3B 4G7

+1 (514) 989-2989 info@braincanada.ca

Please note all online donations will receive an electronic tax receipt, issued by Brain Canada Foundation.

Our Donors

Playing with Marbles Podcast

Join us and take a journey to the real last great frontier – the brain.

Listen

Subscribe to Brain News

Receive our monthly electronic newsletter with updates on funded projects, upcoming events and breakthroughs in brain research.

Sign Up

Territorial acknowledgement

The offices of Brain Canada Foundation are located on the traditional, ancestral territory of the Kanien'kehá:ka Peoples, a place which has long served as a site of meeting and exchange amongst nations. We honour and pay respect to elders past, present and emerging, and dedicate ourselves to moving forward in the spirit of partnership, collaboration, and reconciliation. In our work, we focus our efforts on the Truth and Reconciliation Commission’s Calls to Action, particularly those that pertain to improving health for Indigenous Peoples and that focus on advancing our own learning on Indigenous issues.

© 2026 Brain Canada Foundation

Registration number: 89105 2094 RR0001

  • Terms and Conditions
  • Privacy Policy

Design by Field Trip & Co